Publication not explained
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
Featured Image
Read the Original
This page is a summary of: Changes in LDL-C levels and goal attainment associated with addition of ezetimibe to simvastatin, atorvastatin, or rosuvastatin compared with titrating statin monotherapy, Vascular Health and Risk Management, November 2013, Taylor & Francis,
DOI: 10.2147/vhrm.s49840.
You can read the full text:
Contributors
The following have contributed to this page
